IL17A and Myocardial fibrosis: Conversely, hyperactivation of the IL-23/IL-17 pathway contributes to persistent intestinal inflammation and has been linked to adverse cardiac remodeling and myocardial fibrosis, which can lead to HF [38,39,40,185].